The IV metronidazole group's mortality rate was 38.1% which was much higher than the 7.4% rate of the oral metronidazole group and the 9.5% of the vancomycin group p <0.001.
El grupo de metronidazol IV tuvo una mayor tasa de mortalidad con 38,1% en comparación con 7,4% del metronidazol oral y 9,5% en el grupo de vancomicina oral p< 0,001.